Andra Ap Fonden Quest Diagnostics Inc Transaction History

Andra Ap Fonden

$6.64 Billion
Q3 2024

A detailed history of Andra Ap Fonden transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Andra Ap Fonden holds 31,200 shares of DGX stock, worth $4.28 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

31,200

Previous 33,000 5.45%

Holding current value

$4.28 Million

Previous $4.52 Million 5.31%

% of portfolio

0.06%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$137.09 - $137.09 $246,762 - $246,762	-1,800 Reduced 5.45%	31,200 $4.28 Million
Q2 2024 Aug 07, 2024	SELL	$125.91 - $144.34 $1.89 Million - $2.17 Million	-15,000 Reduced 31.25%	33,000 $4.52 Million
Q1 2024 May 13, 2024	SELL	$123.78 - $142.11 $1.79 Million - $2.06 Million	-14,500 Reduced 23.2%	48,000 $6.39 Million
Q4 2023 Feb 15, 2024	BUY	$120.62 - $141.12 $1.69 Million - $1.98 Million	14,000 Added 28.87%	62,500 $8.62 Million
Q3 2023 Nov 09, 2023	SELL	$121.86 - $144.92 $3.03 Million - $3.61 Million	-24,900 Reduced 33.92%	48,500 $5.91 Million
Q2 2023 Aug 09, 2023	SELL	$130.56 - $146.84 $835,584 - $939,776	-6,400 Reduced 8.02%	73,400 $10.3 Million
Q1 2023 May 12, 2023	BUY	$131.53 - $155.76 $4.17 Million - $4.94 Million	31,700 Added 65.9%	79,800 $11.3 Million
Q4 2022 Feb 13, 2023	SELL	$123.31 - $157.26 $1.74 Million - $2.22 Million	-14,100 Reduced 22.67%	48,100 $7.53 Million
Q3 2022 Nov 14, 2022	BUY	$121.77 - $141.1 $572,319 - $663,170	4,700 Added 8.17%	62,200 $7.63 Million
Q2 2022 Aug 15, 2022	SELL	$127.07 - $145.39 $3.82 Million - $4.38 Million	-30,100 Reduced 34.36%	57,500 $7.65 Million
Q4 2021 Feb 15, 2022	SELL	$140.36 - $173.01 $982,520 - $1.21 Million	-7,000 Reduced 7.4%	87,600 $15.2 Million
Q3 2021 Nov 12, 2021	SELL	$132.95 - $158.0 $1.69 Million - $2.01 Million	-12,700 Reduced 11.84%	94,600 $13.7 Million
Q2 2021 Aug 16, 2021	BUY	$126.66 - $141.48 $5.24 Million - $5.86 Million	41,400 Added 62.82%	107,300 $14.2 Million
Q1 2021 May 17, 2021	SELL	$114.63 - $133.34 $859,725 - $1 Million	-7,500 Reduced 10.22%	65,900 $8.46 Million
Q4 2020 Feb 12, 2021	BUY	$112.7 - $128.05 $1.07 Million - $1.22 Million	9,500 Added 14.87%	73,400 $8.75 Million
Q3 2020 Nov 12, 2020	BUY	$107.05 - $130.01 $834,990 - $1.01 Million	7,800 Added 13.9%	63,900 $7.32 Million
Q2 2020 Aug 06, 2020	SELL	$73.34 - $122.61 $1.17 Million - $1.95 Million	-15,900 Reduced 22.08%	56,100 $6.39 Million
Q1 2020 May 13, 2020	BUY	$75.14 - $115.68 $886,652 - $1.37 Million	11,800 Added 19.6%	72,000 $5.78 Million
Q4 2019 Feb 10, 2020	SELL	$100.29 - $107.99 $441,276 - $475,156	-4,400 Reduced 6.81%	60,200 $6.43 Million
Q3 2019 Nov 19, 2019	BUY	$97.85 - $107.42 $283,765 - $311,518	2,900 Added 4.7%	64,600 $6.91 Million
Q2 2019 Aug 15, 2019	SELL	$85.18 - $101.94 $1.51 Million - $1.8 Million	-17,700 Reduced 22.29%	61,700 $6.28 Million
Q1 2019 May 14, 2019	SELL	$80.68 - $89.92 $1.63 Million - $1.82 Million	-20,200 Reduced 20.28%	79,400 $7.14 Million
Q3 2018 Oct 16, 2018	BUY	$105.42 - $114.99 $1.3 Million - $1.41 Million	12,300 Added 14.09%	99,600 $10.7 Million
Q2 2018 Aug 17, 2018	SELL	$97.35 - $113.14 $1.4 Million - $1.63 Million	-14,400 Reduced 14.16%	87,300 $9.6 Million
Q1 2018 Apr 10, 2018	BUY	$96.42 - $107.88 $1.23 Million - $1.38 Million	12,807 Added 14.41%	101,700 $10.2 Million
Q4 2017 Feb 14, 2018	SELL	$90.86 - $100.24 $373,162 - $411,685	-4,107 Reduced 4.42%	88,893 $8.76 Million
Q3 2017 Oct 31, 2017	BUY	$91.96 - $108.35 $8.55 Million - $10.1 Million	93,000	93,000 $8.71 Million

Others Institutions Holding DGX

# of Institutions

926

Shares Held

95M

Call Options Held

379K

Put Options Held

354K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account